Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript
All right. Good morning, everybody. Why don't we get started? For our first presentation, we're very excited to host Richard Francis. He's the President and CEO of Teva Pharmaceuticals. And we do have Eli Kalif there in the front row. You just want to raise your hand and show everybody. And we got Chris Stevo and Sanjeev Sharma, representing the IR team. So we're happy that everyone could sort of join us.
Well, it was -- 2025 was a gigantic year for Teva, not only financially, I mean, a lot of accomplishments in the pipeline. So maybe as a good place to start, Richard -- I'm sorry, before I should have -- before we do that, I probably should introduce myself. Sorry, this is the first presentation of the conference. So I'm just warming up.
I'm Glen Santangelo. I'm the analyst at Barclays that covers the stock. So please feel free to follow up if anyone has any interest on name afterwards, we'd be happy to spend some time with you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
